Skip to content
10-K

Annual Report

VAXXINITY, INC.

0001562762-23-000132

← back to feed
Filed
Mar 27, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Gross Profit FY 2022 · Dec 31, 2022 $0
Gross Profit FY 2022 · Dec 31, 2021 −$1.87M
Cost Of Revenue FY 2022 · Dec 31, 2022 $0
Cost Of Revenue FY 2022 · Dec 31, 2021 $1.94M
Revenue FY 2022 · Dec 31, 2022 $0
Revenue FY 2022 · Dec 31, 2021 $66K
Shares Diluted FY 2022 · Dec 31, 2021 76.59M sh
Capex FY 2022 · Dec 31, 2021 $1.32M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$80.99M
Short Term Investments FY 2022 · Dec 31, 2021 $0
Cash And Equivalents FY 2022 · Dec 31, 2021 $144.89M
Current Liabilities FY 2022 · Dec 31, 2021 $27.49M
Total Liabilities FY 2022 · Dec 31, 2021 $38.05M
Current Assets restated FY 2022 · Dec 31, 2021 $154.3M
Total Assets FY 2022 · Dec 31, 2021 $166.67M
Eps Diluted FY 2022 · Dec 31, 2021 −$1.79
Eps Basic FY 2022 · Dec 31, 2021 −$1.79
Sga Expense FY 2022 · Dec 31, 2021 $51.83M
Rd Expense FY 2022 · Dec 31, 2021 $71.38M
Net Income FY 2022 · Dec 31, 2021 −$137.18M
Operating Income FY 2022 · Dec 31, 2021 −$125.08M
Stockholders Equity FY 2022 · Dec 31, 2020 −$87.38M